BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Curran M, Simpson D, Perry C. Ertapenem: a review of its use in the management of bacterial infections. Drugs 2003;63:1855-78. [PMID: 12921489 DOI: 10.2165/00003495-200363170-00006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Lima LM, Silva BNMD, Barbosa G, Barreiro EJ. β-lactam antibiotics: An overview from a medicinal chemistry perspective. European Journal of Medicinal Chemistry 2020;208:112829. [DOI: 10.1016/j.ejmech.2020.112829] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
2 Linden P. Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem. Drug Saf 2007;30:657-68. [PMID: 17696578 DOI: 10.2165/00002018-200730080-00002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
3 Yang CC, Wu CH, Lee CT, Liu HT, Chen JB, Chiu CH, Chen CH, Chuang FR. Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy. Int J Infect Dis 2014;28:3-7. [PMID: 25200093 DOI: 10.1016/j.ijid.2014.07.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
4 Goegele H, Berger N, Kafka R, Wenisch C, Tabarelli D, Tabarelli W, Aranda-michel J, Margreiter R, Bonatti H. Course of transplant recipients treated with Ertapenem in the prophylaxis and treatment of infections: a first experience. Eur Surg 2007;39:196-202. [DOI: 10.1007/s10353-007-0326-4] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
5 Zhanel GG, Johanson C, Embil JM, Noreddin A, Gin A, Vercaigne L, Hoban DJ. Ertapenem: review of a new carbapenem. Expert Rev Anti Infect Ther 2005;3:23-39. [PMID: 15757455 DOI: 10.1586/14787210.3.1.23] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
6 Koal T, Deters M, Resch K, Kaever V. Quantification of the carbapenem antibiotic ertapenem in human plasma by a validated liquid chromatography–mass spectrometry method. Clinica Chimica Acta 2006;364:239-45. [DOI: 10.1016/j.cccn.2005.07.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
7 Chen M, Nafziger AN, Drusano GL, Ma L, Bertino JS Jr. Comparative pharmacokinetics and pharmacodynamic target attainment of ertapenem in normal-weight, obese, and extremely obese adults. Antimicrob Agents Chemother 2006;50:1222-7. [PMID: 16569832 DOI: 10.1128/AAC.50.4.1222-1227.2006] [Cited by in Crossref: 75] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
8 Weber DJ, Rutala WA. New Antibiotic Agents: Problems and Prospects. Surgical Infections 2005;6:s-97-s-107. [DOI: 10.1089/sur.2005.6.s2-97] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
9 Collins VL, Marchaim D, Pogue JM, Moshos J, Bheemreddy S, Sunkara B, Shallal A, Chugh N, Eiseler S, Bhargava P. Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2012;56:2173-2177. [PMID: 22290982 DOI: 10.1128/aac.05913-11] [Cited by in Crossref: 40] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
10 Pletz MW, Rau M, Bulitta J, De Roux A, Burkhardt O, Kruse G, Kurowski M, Nord CE, Lode H. Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers. Antimicrob Agents Chemother 2004;48:3765-72. [PMID: 15388432 DOI: 10.1128/AAC.48.10.3765-3772.2004] [Cited by in Crossref: 79] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
11 Corrado MJ, Riselli A, McLaughlin KC, Szumita PM, Anger KE. Safety of Intravenous Push Ertapenem Compared to Intravenous Piggyback at a Tertiary Academic Medical Center. J Pharm Pract 2021;:8971900211038355. [PMID: 34384303 DOI: 10.1177/08971900211038355] [Reference Citation Analysis]
12 El Nekidy WS, Elrefaei H, St John TJL, Attallah NM, Kablaoui F, Nusair A, Piechowski-Jozwiak B, Phillips J, Ghazi IM. Ertapenem Neurotoxicity in Hemodialysis Patients-Safe and Effective Dosing Is Still Needed: A Retrospective Study and Literature Review. Ann Pharmacother 2021;55:52-8. [PMID: 32618479 DOI: 10.1177/1060028020938059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Navarro NS, Campos MI, Alvarado R, Quintero N, Branicki FJ, Wei J, Shivaprakash M, Vrijens F, Giezek H, Chan CY, Dinubile MJ. Ertapenem versus ceftriaxone and metronidazole as treatment for complicated intra-abdominal infections. International Journal of Surgery 2005;3:25-34. [DOI: 10.1016/j.ijsu.2005.03.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
14 Keating GM, Perry CM. Ertapenem: a review of its use in the treatment of bacterial infections. Drugs 2005;65:2151-78. [PMID: 16225376 DOI: 10.2165/00003495-200565150-00013] [Cited by in Crossref: 68] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
15 Shah NJ. Reversing resistance: The next generation antibacterials. Indian J Pharmacol 2015;47:248-55. [PMID: 26069360 DOI: 10.4103/0253-7613.157109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Shahid M, Sobia F, Singh A, Malik A, Khan HM, Jonas D, Hawkey PM. Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update. Crit Rev Microbiol 2009;35:81-108. [PMID: 19514910 DOI: 10.1080/10408410902733979] [Cited by in Crossref: 87] [Cited by in F6Publishing: 69] [Article Influence: 6.7] [Reference Citation Analysis]
17 Seto AH, Song JC, Guest SS. Ertapenem-Associated Seizures in a Peritoneal Dialysis Patient. Ann Pharmacother 2005;39:352-6. [DOI: 10.1345/aph.1e421] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]